Argeris N. Karabelas, Chairman of the Board at Vanda Pharmaceuticals Inc. (VNDA), sold 50,000 shares at $14.55 ($728K) on 2006-11-21, disclosed to the SEC on 2006-11-22.
Open-market sale of $728k VNDA by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.55 | 3,210 | $47K | 6.4% |
| 2 | $14.55 | 46,790 | $681K | 93.6% |
| Total | $14.55 avg | 50,000 | $728K | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |